Trevena

Trevena

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Suggest edits
Founded
2007
Raised
$164M
Follow us
Companies in the same industry
Alexa global traffic share
Twitter followers
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4

Add info
Add round
05 Nov 2014
$45,000,000
Post-IPO equity
09 May 2013
$60,000,000
Venture capital (Series C)
Forest Laboratories
14 Jul 2010
$35,000,000
Venture capital (Series B)
Polaris Partners, Alta Partners, NEA, +1
01 Mar 2008
$24,000,000
Venture capital (Series A)
Polaris Partners, Alta Partners, NEA, +1